These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 19736231)

  • 1. Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration.
    Petrovic M; de Alda MJ; Diaz-Cruz S; Postigo C; Radjenovic J; Gros M; Barcelo D
    Philos Trans A Math Phys Eng Sci; 2009 Oct; 367(1904):3979-4003. PubMed ID: 19736231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fate and distribution of pharmaceuticals in wastewater and sewage sludge of the conventional activated sludge (CAS) and advanced membrane bioreactor (MBR) treatment.
    Radjenović J; Petrović M; Barceló D
    Water Res; 2009 Feb; 43(3):831-41. PubMed ID: 19091371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas.
    Heberer T; Reddersen K; Mechlinski A
    Water Sci Technol; 2002; 46(3):81-8. PubMed ID: 12227607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fate of pharmaceuticals and personal care products in wastewater treatment plants--conception of a database and first results.
    Miège C; Choubert JM; Ribeiro L; Eusèbe M; Coquery M
    Environ Pollut; 2009 May; 157(5):1721-6. PubMed ID: 19201071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The occurrence of illicit and therapeutic pharmaceuticals in wastewater effluent and surface waters in Nebraska.
    Bartelt-Hunt SL; Snow DD; Damon T; Shockley J; Hoagland K
    Environ Pollut; 2009 Mar; 157(3):786-91. PubMed ID: 19110357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fate of pharmaceuticals during indirect potable reuse.
    Drewes JE; Heberer T; Reddersen K
    Water Sci Technol; 2002; 46(3):73-80. PubMed ID: 12227606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data, Part 2: Pharmaceuticals as chemical markers of faecal water contamination.
    Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
    Environ Pollut; 2009 Jun; 157(6):1778-86. PubMed ID: 19299056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Illicit drugs in the environment.
    Zuccato E; Castiglioni S
    Philos Trans A Math Phys Eng Sci; 2009 Oct; 367(1904):3965-78. PubMed ID: 19736230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Occurrence and removal of pharmaceuticals and endocrine disruptors in South Korean surface, drinking, and waste waters.
    Kim SD; Cho J; Kim IS; Vanderford BJ; Snyder SA
    Water Res; 2007 Mar; 41(5):1013-21. PubMed ID: 16934312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant.
    Clara M; Strenn B; Ausserleitner M; Kreuzinger N
    Water Sci Technol; 2004; 50(5):29-36. PubMed ID: 15497826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters.
    Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
    Water Res; 2009 Feb; 43(2):363-80. PubMed ID: 19022470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of residual organic macromolecules produced in biological wastewater treatment processes on removal of pharmaceuticals by NF/RO membranes.
    Kimura K; Iwase T; Kita S; Watanabe Y
    Water Res; 2009 Aug; 43(15):3751-8. PubMed ID: 19564034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Environmental aspects of wastewater reclamation.
    Sharma S; Choudhary MP
    J Environ Sci Eng; 2007 Jul; 49(3):235-40. PubMed ID: 18476450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater.
    Kreuzinger N; Clara M; Strenn B; Kroiss H
    Water Sci Technol; 2004; 50(5):149-56. PubMed ID: 15497842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Illicit drugs: contaminants in the environment and utility in forensic epidemiology.
    Daughton CG
    Rev Environ Contam Toxicol; 2011; 210():59-110. PubMed ID: 21170703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation on the behaviour of selected pharmaceuticals in the groundwater after infiltration of treated wastewater.
    Kreuzinger N; Clara M; Strenn B; Vogel B
    Water Sci Technol; 2004; 50(2):221-8. PubMed ID: 15344795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Membrane processes for removal of pharmaceutically active compounds (PhACs) from water and wastewaters.
    Taheran M; Brar SK; Verma M; Surampalli RY; Zhang TC; Valero JR
    Sci Total Environ; 2016 Mar; 547():60-77. PubMed ID: 26789358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants.
    Clara M; Strenn B; Gans O; Martinez E; Kreuzinger N; Kroiss H
    Water Res; 2005 Nov; 39(19):4797-807. PubMed ID: 16242170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment.
    Strenn B; Clara M; Gans O; Kreuzinger N
    Water Sci Technol; 2004; 50(5):269-76. PubMed ID: 15497857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Removal of pharmaceuticals and fragrances in biological wastewater treatment.
    Joss A; Keller E; Alder AC; Göbel A; McArdell CS; Ternes T; Siegrist H
    Water Res; 2005 Sep; 39(14):3139-52. PubMed ID: 16043210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.